vs
Side-by-side financial comparison of ACI WORLDWIDE, INC. (ACIW) and Amneal Pharmaceuticals, Inc. (AMRX). Click either name above to swap in a different company.
Amneal Pharmaceuticals, Inc. is the larger business by last-quarter revenue ($722.5M vs $425.7M, roughly 1.7× ACI WORLDWIDE, INC.). Amneal Pharmaceuticals, Inc. runs the higher net margin — 10.8% vs 9.0%, a 1.8% gap on every dollar of revenue. On growth, ACI WORLDWIDE, INC. posted the faster year-over-year revenue change (7.9% vs 3.9%). Over the past eight quarters, ACI WORLDWIDE, INC.'s revenue compounded faster (6.8% CAGR vs 1.5%).
ACI Worldwide is a digital payments software company headquartered in Elkhorn, Nebraska, that processes billions of transactions daily equating to trillions of U.S. dollars for customers in 94 countries. Banks, financial institutions, merchants, billers, acquirers, issuers, and other third-party payment service providers use its intelligent solutions to deploy secure payment rails across all channels.
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
ACIW vs AMRX — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $425.7M | $722.5M |
| Net Profit | $38.3M | $78.0M |
| Gross Margin | — | 44.3% |
| Operating Margin | 13.5% | 19.6% |
| Net Margin | 9.0% | 10.8% |
| Revenue YoY | 7.9% | 3.9% |
| Net Profit YoY | — | 410.5% |
| EPS (diluted) | $0.37 | $0.19 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $425.7M | $722.5M | ||
| Q4 25 | $481.6M | $814.3M | ||
| Q3 25 | $482.4M | $784.5M | ||
| Q2 25 | $401.3M | $724.5M | ||
| Q1 25 | $394.6M | $695.4M | ||
| Q4 24 | $453.0M | $730.5M | ||
| Q3 24 | $451.8M | $702.5M | ||
| Q2 24 | $373.5M | $701.8M |
| Q1 26 | $38.3M | $78.0M | ||
| Q4 25 | $64.3M | $35.1M | ||
| Q3 25 | $91.3M | $2.4M | ||
| Q2 25 | $12.2M | $22.4M | ||
| Q1 25 | $58.9M | $12.2M | ||
| Q4 24 | $98.6M | $-31.1M | ||
| Q3 24 | $81.4M | $-156.0K | ||
| Q2 24 | $30.9M | $6.0M |
| Q1 26 | — | 44.3% | ||
| Q4 25 | 53.0% | 36.5% | ||
| Q3 25 | 53.7% | 34.9% | ||
| Q2 25 | 41.5% | 39.5% | ||
| Q1 25 | 45.9% | 36.8% | ||
| Q4 24 | 55.8% | 36.0% | ||
| Q3 24 | 56.3% | 38.4% | ||
| Q2 24 | 45.6% | 35.6% |
| Q1 26 | 13.5% | 19.6% | ||
| Q4 25 | 22.6% | 13.8% | ||
| Q3 25 | 26.5% | 9.0% | ||
| Q2 25 | 8.7% | 15.4% | ||
| Q1 25 | 14.8% | 14.4% | ||
| Q4 24 | 27.0% | 10.4% | ||
| Q3 24 | 27.1% | 12.6% | ||
| Q2 24 | 14.4% | 13.6% |
| Q1 26 | 9.0% | 10.8% | ||
| Q4 25 | 13.4% | 4.3% | ||
| Q3 25 | 18.9% | 0.3% | ||
| Q2 25 | 3.0% | 3.1% | ||
| Q1 25 | 14.9% | 1.8% | ||
| Q4 24 | 21.8% | -4.3% | ||
| Q3 24 | 18.0% | -0.0% | ||
| Q2 24 | 8.3% | 0.9% |
| Q1 26 | $0.37 | $0.19 | ||
| Q4 25 | $0.61 | $0.10 | ||
| Q3 25 | $0.88 | $0.01 | ||
| Q2 25 | $0.12 | $0.07 | ||
| Q1 25 | $0.55 | $0.04 | ||
| Q4 24 | $0.92 | $-0.10 | ||
| Q3 24 | $0.77 | $0.00 | ||
| Q2 24 | $0.29 | $0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $161.8M | $197.7M |
| Total DebtLower is stronger | $807.4M | — |
| Stockholders' EquityBook value | $1.5B | — |
| Total Assets | $3.1B | $3.5B |
| Debt / EquityLower = less leverage | 0.54× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $161.8M | $197.7M | ||
| Q4 25 | $196.5M | $282.0M | ||
| Q3 25 | $199.3M | $201.2M | ||
| Q2 25 | $189.7M | $71.5M | ||
| Q1 25 | $230.1M | $59.2M | ||
| Q4 24 | $216.4M | $110.6M | ||
| Q3 24 | $177.9M | $74.0M | ||
| Q2 24 | $157.0M | $43.8M |
| Q1 26 | $807.4M | — | ||
| Q4 25 | $817.6M | $2.6B | ||
| Q3 25 | $867.8M | $2.6B | ||
| Q2 25 | $898.0M | $2.2B | ||
| Q1 25 | $845.9M | $2.2B | ||
| Q4 24 | $924.6M | $2.4B | ||
| Q3 24 | $994.3M | $2.4B | ||
| Q2 24 | $1.0B | $2.4B |
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.5B | $-70.8M | ||
| Q3 25 | $1.5B | $-109.5M | ||
| Q2 25 | $1.4B | $-112.1M | ||
| Q1 25 | $1.5B | $-131.7M | ||
| Q4 24 | $1.4B | $-109.3M | ||
| Q3 24 | $1.3B | $-93.4M | ||
| Q2 24 | $1.2B | $-57.5M |
| Q1 26 | $3.1B | $3.5B | ||
| Q4 25 | $3.1B | $3.7B | ||
| Q3 25 | $3.2B | $3.6B | ||
| Q2 25 | $3.1B | $3.4B | ||
| Q1 25 | $3.2B | $3.4B | ||
| Q4 24 | $3.0B | $3.5B | ||
| Q3 24 | $3.1B | $3.5B | ||
| Q2 24 | $3.4B | $3.5B |
| Q1 26 | 0.54× | — | ||
| Q4 25 | 0.54× | — | ||
| Q3 25 | 0.59× | — | ||
| Q2 25 | 0.64× | — | ||
| Q1 25 | 0.57× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | 0.75× | — | ||
| Q2 24 | 0.82× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACIW
| Software as a service and platform as a service | $262.0M | 62% |
| License | $88.0M | 21% |
| Maintenance | $50.9M | 12% |
| Services | $24.8M | 6% |
AMRX
Segment breakdown not available.
